Talking Points

TCTMD

A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe. 06f763f0-76e5-11f0-bb7c-8557ae1d8a8b

  1. vor 2 Tagen

    The PRAGUE-25 Study

    Pavel Osmancik and C. Michael Gibson discuss whether catheter ablation is superior to risk factor modification with antiarrythmic drugs for the treatment of AF.

  2. 22. Juli

    The BETAMI-DANBLOCK Trial

    How does discontinuing beta-blockers after MI affect outcomes in patients without HF? Dan Atar and C. Michael Gibson break it down.

  3. 1. Juli

    New York Valves 2026: Implications of the Proposed National Coverage Determination for TAVI

    In one of the most thought-provoking sessions at New York Valves 2026, Michael Mack and Roxana Mehran moderate a panel discussion looking at the future of TAVI from all angles.

  4. 3. Juni

    The PROCTOR Trial

    Ruben de Winter and C. Michael Gibson compare clinical outcomes of native vessel versus SVG PCI for patients with prior CABG.

  5. 20. Mai

    The SELUTION DeNovo Trial

    Christian M. Spaulding and C. Michael Gibson look at the 1-year results from the study comparing sirolimus-eluting DCB with DES for de novo coronary lesions.

  6. 6. Mai

    The VESALIUS-CV Trial

    Paul Burton and C. Michael Gibson discuss the effects of adding evolocumab for patients at high risk for CV events but without prior MI or stroke.

  7. 22. Apr.

    The META-AF Trial

    Amrish Deshmukh talks to C. Michael Gibson about the use of metformin as an adjunctive therapy to catheter ablation of AF.

  8. 1. Apr.

    Evolution of Pharmacotherapy in STEMI

    How has the pharmacotherapy for STEMI changed over the past 46 years? Ginger Jiang and C. Michael Gibson discuss treating patients with zalunfiban at first medical contact.

Alle anzeigen (210)

Info

A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe. 06f763f0-76e5-11f0-bb7c-8557ae1d8a8b

Informationen

  • Erstellt von
    TCTMD
  • Jahre aktiv
    2016 - 2026
  • Folgen
    210
  • Bewertung
    Unbedenklich
  • Copyright
    © All rights reserved
  • Sendungswebsite
    Talking Points

Das gefällt dir vielleicht auch